AVIL-NU
Manufacturer Details
SANOFI AVENTIS
SANOFI INDIA LTD
SANOFI HOUSE, CTS NO 117-B
L&T BUSINESS PARK
SAKI VIHAR ROAD, POWAI
ANDHERI EAST, MUMBAI 400072
Compositions:
Cetrizine dihcl 10mg tablets,
Strength
|
Rate
|
Packing Style
|
10mg
|
17.36
|
10s tablets
|
List of Related Indications:
- Symptom treat of allerg rhinit
List Of Drugs:
- Cetirizine dihydrochloride @ - Antihistamines
Indication Type Description:
Pharmacology/ Pharmacokinetics
Drug Interaction:
Antihistamines Include:
First Generation ( Non-selective )
Ethanolamine-
Carbinoxamine. Clemastine, Diphenhydramine. Ethylenediamines- Pyrilamine, Triplennamine Akylamines- Brompheneramine, Chlorpheniramine, Dexchlor pheniramine,Pheniramine,Triprolidine Phenothiazines- Methidilazine, Promethizine, trimeprazine
Piperidines- Azatadine, Cyproheptadine, Phenindamine Miscellaneous- Astemazole, Loratadine, Terfenadine Second Generation ( Peripherally selective ) Phthalazinone - Azelastine Piperazine - Cetrizine Refer - Chlorpheniramine maleate
Studies with diazepam and cimetidine have revealed no evidence of interactions.
As with other antihistamines, it is advisable to avoid excessive alcohol consumption. CNS depressants
Indication:
Allergic disorders
Antihistamines Include: First Generation ( Non-selective )
Ethanolamine- Carbinoxamine. Clemastine, Diphenhydramine. Ethylenediamines- Pyrilamine, Triplennamine Akylamines- Brompheneramine, Chlorpheniramine, Dexchlor pheniramine,Pheniramine,Triprolidine Phenothiazines- Methidilazine, Promethizine, trimeprazine
Piperidines- Azatadine, Cyproheptadine, Phenindamine Miscellaneous- Astemazole, Loratadine, Terfenadine Second Generation ( Peripherally selective ) Phthalazinone - Azelastine Piperazine - Cetrizine Refer - Chlorpheniramine maleate
Adverse Reaction:
Occasional reports of mild and transcient subjective side effects such as headache, dizziness, drowsiness, agitation, dry mouth, and GI discomfort.
Occasional symptoms of hypersensitivity have been reported.
Contra-Indications:
Hypersens to the drug,lactation.
Special precautions:
Do not exceed recommended dosage.
Caution while driving or operating machinary. Elderly with reduced renal function.
Renal impairment
Dosages/ Overdosage Etc:
Approved by FDA on December 12,1995..
Indications:
Allergic disorders
Dosage:
5,10 and 20mg/day for once daily treatment of seasonal and allergic rhinitis,allergic rhinitis and chronic idiopathic urticaria.
Patient Information:
Antihistamines Include: First Generation ( Non-selective )
Ethanolamine- Carbinoxamine. Clemastine, Diphenhydramine. Ethylenediamines- Pyrilamine, Triplennamine Akylamines- Brompheneramine, Chlorpheniramine, Dexchlor pheniramine,Pheniramine,Triprolidine Phenothiazines- Methidilazine, Promethizine, trimeprazine
Piperidines- Azatadine, Cyproheptadine, Phenindamine Miscellaneous- Astemazole, Loratadine, Terfenadine Second Generation ( Peripherally selective ) Phthalazinone - Azelastine Piperazine - Cetrizine Refer - Chlorpheniramine maleate
Pharmacology/ Pharmacokinetics:
Refer antihistamines
Interaction with Food:
Reduction in rate but not extent of absorption
Pregnancy and lactation:
Refer antihistamines